| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 58.199 | 68.886 | 75.520 | 76.072 | 94.944 | 126.081 | 137.281 |
| Total Income - EUR | - | - | 0 | 58.199 | 68.889 | 75.532 | 76.087 | 94.954 | 126.087 | 137.291 |
| Total Expenses - EUR | - | - | 0 | 17.976 | 31.683 | 15.511 | 15.972 | 22.668 | 19.432 | 40.092 |
| Gross Profit/Loss - EUR | - | - | 0 | 40.223 | 37.206 | 60.021 | 60.115 | 72.286 | 106.655 | 97.199 |
| Net Profit/Loss - EUR | - | - | 0 | 39.641 | 36.517 | 59.317 | 59.354 | 71.336 | 105.394 | 93.080 |
| Employees | - | - | 0 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gospamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 151 | 331 | 255 | 842 | 2.510 |
| Current Assets | - | - | 44 | 41.353 | 38.802 | 60.399 | 60.180 | 84.252 | 108.243 | 88.032 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 442 | 0 | 0 |
| Receivables | - | - | 0 | 4.222 | 4.341 | 2.684 | 27.390 | 52.506 | 80.941 | 63.239 |
| Cash | - | - | 44 | 37.131 | 34.461 | 57.715 | 32.790 | 31.305 | 27.302 | 24.793 |
| Shareholders Funds | - | - | 44 | 39.684 | 36.835 | 59.366 | 59.403 | 71.385 | 105.442 | 93.128 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 1.669 | 1.966 | 1.184 | 1.108 | 13.122 | 3.643 | 2.283 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gospamed S.r.l.